Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic review
Abstract Mantle cell lymphoma (MCL) is a rare B‐cell non‐Hodgkin lymphoma (NHL) that is aggressive and incurable with existing therapies, presenting a significant unmet clinical need. MCL occurs mainly in elderly patients with comorbidities; thus, intense treatment options including allogeneic stem...
Main Authors: | Tahera Alnassfan, Megan J. Cox‐Pridmore, Azzam Taktak, Kathleen J Till |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.311 |
Similar Items
-
Skin Manifestations associated with Mantle cell Lymphoma: a case report
by: avinash kumar singh, et al.
Published: (2013-02-01) -
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
by: Ujjani C, et al.
Published: (2020-08-01) -
Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib – Case Report
by: Danuta Krasowska, et al.
Published: (2020-09-01) -
Tackling Mantle Cell Lymphoma in Europe
by: Denis Horgan, et al.
Published: (2022-09-01) -
Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
by: Samer Alkhalili, et al.
Published: (2023-01-01)